Affiliation: | (1) Department of Medical Oncology, Rotterdam Cancer Institute (Daniel den Hoed Kliniek) and University Hospital Rotterdam, Rotterdam, The Netherlands;(2) SmithKline Beecham Pharmaceuticals, New Frontiers Science Park (South), Harlow, Essex, UK |